Statins & Dementia
Disclaimer: Not Medical Advice. Opinions are my own.
Was this newsletter forwarded to you? Subscribe here
In partnership with Function
Get 160+ lab tests detecting 1000+ health conditions.
Today's Newsletter at a Glance:
- Cholesterol is Essential for Life
- Your Brain's Cholesterol Factory
- The Data on Dementia & Statins
- The Bottom Line
Cholesterol is necessary.
If you had zero cholesterol, you wouldn't be alive.
Cholesterol is a structural part of the membrane around every cell in your body.
It’s the raw material for vitamin D, steroid hormones like testosterone, estrogen, and cortisol, and bile acids that help you digest fat.
Because it’s so essential, your body doesn’t leave the supply to chance.
Nearly every cell in your body can make its own cholesterol.
Dietary intake is only part of the picture. Your liver does much of the work.
So what’s the bloodstream’s job? Think of it as the shipping network.
Cholesterol doesn’t dissolve in blood, so it travels packaged inside lipoproteins.
Each atherogenic lipoprotein (LDL, VLDL, IDL, and Lp(a)) carries one ApoB protein on its surface.
That makes ApoB a direct count of the particles moving cholesterol around your body.
When too many ApoB particles are in circulation, they can penetrate the artery wall, get stuck, and start the atherosclerosis process.
The more particles you have, and the longer you’re exposed to them, the more plaque you build.
Statins remain first-line therapy for lowering ApoB.
Does lowering cholesterol harm the brain?
Your brain runs its own cholesterol factory
Your brain holds roughly a quarter of your body's cholesterol.
Most of that sits in myelin, the insulating sheath that wraps nerve fibers and lets signals travel fast. Cholesterol is also critical for synapses, the connections between neurons.
But the brain doesn’t get its cholesterol from your bloodstream.
The blood-brain barrier keeps lipoproteins out. The LDL particles in your blood stay on the vascular side of the wall.
Some statins (lipophilic) can cross into the brain and modestly slow its own cholesterol production. But brain cholesterol turns over extremely slowly, and studies show the brain’s total supply stays essentially unchanged.
The takeaway: your brain’s cholesterol supply is largely a closed system, separate from your lipid panel.
The Data on Statins & Dementia
Biology is a starting point. Data is what matters. Here’s what the research shows.
- Observational data. A meta-analysis of 25 cohort studies (millions of participants) found statin users had about a 15% lower risk of all-cause dementia and roughly a 28% lower risk of Alzheimer disease, with no effect on vascular dementia. A larger synthesis reported similar numbers: a decreased risk of dementia across 36 studies and of Alzheimer disease across 21 studies, with similar risks for lipophilic and hydrophilic statins.
- An umbrella review confirms consistency. In an umbrella review, pooled estimates for dementia risk reduction with statins across seven meta-analyses ranged from about 15% to 38%, with signals of a dose- and duration-response relationship.
- The STAREE trial provides the strongest test yet. The STAREE trial included 9,971 community-dwelling adults 70 or older with no history of cardiovascular disease, diabetes, or dementia who were randomized to atorvastatin 40 mg daily or placebo and followed for a median of 5.9 years. It was the first large statin trial in older adults to include dementia in a prespecified primary endpoint. Dementia occurred at nearly identical rates. The composite of death, dementia, or persistent physical disability was not significantly different. Atorvastatin did lower major cardiovascular events. Statins still earn their place in older adults for heart protection, but STAREE shows no added protection against dementia.
What About Side Effects?
No drug is free of side effects, and statins are no exception.
Muscle symptoms are the most common complaint. In 2022, researchers pooled data from 19 large double-blind trials with nearly 124,000 people. Muscle pain or weakness was reported by 27.1% of people on a statin and 26.6% of people on placebo. In the first year, only about 1 in 15 of those muscle complaints were actually caused by the statin. After that, there was no excess.
Statins also cause a small rise in blood sugar, which can push people already near the line into a diabetes diagnosis. They can also cause minor, usually harmless, changes in liver tests.
What about memory? Some people do report brain fog or forgetfulness on a statin. Back in 2012, the FDA added language to statin labels based on case reports. Those experiences are real to the people having them. If it happens to you, tell your doctor. Switching statins or adjusting the dose often solves it.
But here’s what the best evidence shows. In 2026, the same research group went through 66 side effects listed on statin labels and checked each against blinded trial data. Cognitive impairment was not supported, and neither were depression, sleep problems, or nerve pain. The authors called for the labels to be revised.
And to be clear: even when someone does experience memory complaints on a statin, there’s no evidence it leads to dementia. Population studies suggest less dementia, and the randomized trials show no increase.
The Bottom Line
Every medication has side effects.
Even aspirin or common blood pressure medications.
Doing nothing has risk as well. For cholesterol, the downside of doing nothing is plaque, building quietly for decades until it shows up as a heart attack or stroke.
Side effects are a reason to talk to your doctor.
Discuss switching to a different statin, lowering the dose, adding ezetimibe, or using an alternative such as a PCSK9 inhibitor.
Side effects are not a reason to completely turn your back on the burden of evidence.
Your brain makes its own cholesterol.
Your arteries don’t need the excess ApoB in your blood.
Protect both.
Knowing Your ApoB Levels
Apolipoprotein B (ApoB) is not included in a standard lipid panel and is rarely included on routine annual labs.
That's starting to change. The new 2026 ACC/AHA cholesterol guidelines now formally recommend ApoB testing to refine risk assessment in certain patients — because ApoB directly quantifies the number of atherogenic lipoproteins, providing a more accurate measure of atherogenic particle burden than LDL-C.
Essentially, ApoB counts the actual number of artery-clogging particles in your blood, which can be a more accurate measure of risk than LDL-C alone.
Function Health is an all-in-one health platform that starts with 160+ lab tests, covering your heart, hormones, liver, kidneys, thyroid, immune system, cancer signals, toxins, and key nutrients.
That’s about 5× as much testing as standard primary care labs—bloodwork that would normally cost thousands of dollars out of pocket.
Scheduling is simple, with 2,000+ lab locations across the U.S., and most visits take around 15 minutes.
If you are interested in knowing your ApoB level, see if Function is a good fit for you.
Click here to sign up for Function Health for less than $1/day
I want to hear from you!
Was this newsletter edition helpful?
Did you learn from this newsletter?
(Respond directly to this email. I read all responses)
Only the best,
Jeremy London, MD
P.S. Don't forget to follow my podcast for free on Spotify or Apple Podcasts
Featured in Today's Newsletter:
|
Before you go...
Want to read past Newsletters? Click Here
|
* Disclaimer: This blog is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this blog or materials linked from this blog is at the user’s own risk. The content of this blog is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay seeking medical advice for any medical condition they may have and should consult their healthcare professionals for any such conditions.
Stay connected on all my platforms:
